XML 27 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Expenses:    
Research and development $ 2,881,967 $ 4,794,549
General and administrative 4,132,777 4,428,209
Loss from operations (7,014,744) (9,222,758)
Other income (loss):    
Reimbursement grant income 698,277 581,039
Interest income 153,498 289,846
Misc other income 14,766 0
Foreign exchange loss (21,042) (21,742)
Nonoperating Income (Expense) 845,499 849,143
Loss before income taxes (6,169,245) (8,373,615)
Income tax expense 800 800
Net loss (6,170,045) (8,374,415)
Exchange differences on translation (27,965) (1,046)
Net comprehensive loss $ (6,198,010) $ (8,375,461)
Weighted average number of common shares (in shares) 3,197,423 2,858,929
Loss per common share - basic and diluted (in dollars per share) $ (1.93) $ (2.93)